SCHEDULE: Vanguard Group Amends Xylem Stake to Zero
Beneficial Ownership Amendment
The Vanguard Group has filed an amended Schedule 13G, reporting zero beneficial ownership in Xylem Inc/NY common stock following an internal realignment.
Summary
- The Vanguard Group filed an Amendment No. 14 to Schedule 13G for Xylem Inc/NY common stock (CUSIP: 98419M100).
- The filing reports 0.00 shares beneficially owned, representing 0% of the class.
- This change is a result of an internal realignment within The Vanguard Group, Inc. that occurred on January 12, 2026.
- Following the realignment, certain subsidiaries or business divisions of The Vanguard Group, Inc. will now report beneficial ownership separately (on a disaggregated basis).
- The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over the securities beneficially owned by these disaggregated subsidiaries and/or business divisions.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, primarily administrative in nature, reflecting an internal organizational change by The Vanguard Group rather than a change in investment thesis regarding Xylem Inc.
Future Outlook
NA
Management Comments
- On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment.
- Certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release.
- The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.
Industry Context
StockSavvy.ai notes that institutional investors like The Vanguard Group frequently adjust their reporting structures, especially for large, diversified funds. This realignment reflects a common practice among major asset managers to disaggregate reporting for specific subsidiaries or investment vehicles, which can enhance transparency for individual fund holdings while simplifying the parent entity's aggregate reporting.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Reporting Structure | The Vanguard Group, Inc. underwent an internal realignment, leading to certain subsidiaries or business divisions reporting beneficial ownership separately (on a disaggregated basis). | 2026-01-12 | This change impacts how beneficial ownership of Xylem Inc. common stock is reported by Vanguard entities, shifting from an aggregated view to a disaggregated one for specific subsidiaries, potentially increasing transparency at the subsidiary level. |
Stakeholder Impact
- Shareholders of Xylem Inc.: No direct impact on Xylem's operations or value, but a change in how a major institutional investor's holdings are reported.
- Investors in Vanguard funds: May see more granular reporting of Xylem holdings within specific Vanguard subsidiaries or funds.
Key Dates
| Date | Description |
|---|---|
| 2026-01-12 | Internal realignment within The Vanguard Group, Inc. |
| 2026-03-13 | Date of event requiring the filing of this statement. |
| 2026-03-27 | Date of signature for the Schedule 13G/A filing. |
Keywords
Vanguard Group, Xylem Inc, Schedule 13G, Beneficial Ownership, Institutional Investor, SEC Filing, Common Stock, Investment Adviser, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.